TrialJournal for immunotherapy of cancer2024

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial.

Heinz-Josef Lenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.